Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 07 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

The approval allows Zydus to manufacture the product at its facility in Moraiya, Ahmedabad. Tadalafil is used to treat pulmonary arterial hypertension and improve exercise capacity. The press release highlights that Tadalafil Tablets had significant annual sales in the United States.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases